Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical Rheumatology|October 23, 2020
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?Tracy M Frech, John M VanBuren, Emily Startup, et al.
International Journal of Rheumatic Diseases|November 29, 2021
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registryFlavia V Castelino, John M VanBuren, Emily Startup, et al.
Clinical and Experimental Rheumatology|July 27, 2023
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
The Journal of Rheumatology|October 3, 2018
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS RegistryVivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Annals of the Rheumatic Diseases|November 27, 2019
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profileBrian Skaug, Dinesh Khanna, William R Swindell, et al.
Rheumatology (Oxford, England)|April 20, 2023
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilizationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
The Journal of Rheumatology|January 15, 2025
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic SclerosisJeong Min Yu, John M VanBuren, Angela Child, et al.
The Journal of Rheumatology|November 15, 2025
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosisAli Y Ayla, Elana J Bernstein, Meng Zhang, et al.
Pageof 4